Today: 11 June 2026
Macquarie share price: MQG heads into Australia Day pause with CPI and rate bets in focus
25 January 2026
1 min read

Macquarie share price: MQG heads into Australia Day pause with CPI and rate bets in focus

SYDNEY, Jan 25, 2026, 17:28 AEDT — Market closed

  • Macquarie Group Ltd (ASX: MQG) ended the day at A$210.41, slipping 0.22%.
  • The ASX will be closed Monday for Australia Day. Trading resumes Tuesday, ahead of Australia’s CPI release on Wednesday, Jan. 28.

Shares of Macquarie Group Ltd slid slightly ahead of the Australia Day holiday, with local markets closed until Tuesday and a crucial inflation report due midweek.

Timing is crucial. A holiday-shortened week tends to amplify market swings, and investors will focus on Wednesday’s inflation report to see if it tightens bets on a rate hike in early February.

Macquarie finds itself caught in the middle of this debate as it operates both as a lender and a markets-facing entity. Changes in rate bets drive bank stock movements, along with shifts in deal flow, trading environments, and asset valuations.

The broader market edged up on Friday. The S&P/ASX 200 finished 0.13% higher at 8,860.09, making Macquarie’s modest drop stand out as a rare underperformer heading into the weekend.

Rate-sensitive financial stocks dipped 0.5%, wiping out gains seen in miners and tech, according to a Reuters market update. Marc Jocum, investment strategist at Global X ETFs Australia, noted banks could face rising pressure on their “cost-to-income ratios” if higher rates start to curb mortgage demand. Indo Premier

The Australian dollar gained ground late Friday, hovering around 68.47 U.S. cents, per an ABC market update. A rising Aussie can weigh on offshore earnings once converted back into local currency — a current concern for multinational firms like Macquarie.

Offshore, investors face a Federal Reserve meeting spanning Jan. 27–28, with the rate decision set for the second day. Sharp moves in global bond yields often ripple through bank valuations and risk sentiment fast.

Traders at home are zeroing in on one key date: the Australian Bureau of Statistics will release the December-quarter CPI on Wednesday, Jan. 28. This inflation figure is crucial as it drives expectations around interest rates.

The Reserve Bank of Australia will hold its next policy meeting on Feb. 2–3. Should inflation data come in hotter than expected, traders might ramp up bets on a 25 basis point hike—a quarter-point increase—at that gathering.

But the setup works both ways. A soft inflation reading might ease rate worries and support financials, while a hotter print could trigger a sharper yield repricing that usually weighs on the sector, Macquarie included.

Investors have Macquarie’s 2026 operational briefing marked for Feb. 10, with the full-year results due May 8.

The ASX is closed Monday, putting the spotlight on Tuesday’s reopening as the next hurdle for Macquarie shares. Wednesday’s CPI release follows closely, alongside the Fed decision. Macquarie’s own briefing date is also gaining attention.

Stock Market Today

  • What is an IPO as SpaceX Prepares for U.S. Stock Market Debut
    June 10, 2026, 6:01 PM EDT. An IPO, or Initial Public Offering, is when a private company sells shares to the public for the first time, becoming publicly traded. SpaceX, the aerospace manufacturer, is expected to make its debut on the U.S. stock market, marking one of the most anticipated IPOs in recent years. This move allows retail and institutional investors to buy equity in SpaceX, potentially impacting the space industry and tech sectors. The IPO process involves regulatory filings, pricing, and public trading, providing companies with capital for expansion. SpaceX's offering could reshape market dynamics, drawing significant investor interest given its innovations and growth trajectory.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Cloud computing stocks face a packed week as Amazon job cuts loom and Fed meets
Previous Story

Cloud computing stocks face a packed week as Amazon job cuts loom and Fed meets

Tencent stock price: Nvidia H200 chip orders loom as 0700.HK heads into Monday
Next Story

Tencent stock price: Nvidia H200 chip orders loom as 0700.HK heads into Monday

Go toTop